Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LYNPROTEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Lyn — Proto Oncogene Tyrosine Protein Kinase Lyn is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
No AI portrait yet
| Gene Symbol | LYNPROTEIN |
| Chromosome | 8q13.1. |
| Protein Type | Receptor |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Primary Expression | hematopoietic cells (B lymphocytes, myeloid cells, mast cells) and in microglia, where it serves as both a |
| Subcellular Localization | ** | Plasma membrane, Cytoplasm, Endosomes | |
| Molecular Weight | 56 kDa |
| Amino Acids | 21 aa |
| GeneCards | LYNPROTEIN |
| Human Protein Atlas | LYNPROTEIN |
| Unique domain (residues 1-65) | Lyn-specific sequences that determine substrate specificity; contains binding sites for immune receptors |
| SH3 domain (residues 68-125) | Binds proline-rich sequences; autoinhibitory function |
| SH2 domain (residues 130-205) | Phosphotyrosine binding; regulatory interactions |
| C-terminal tail | Tyr508 (human) phosphorylation by CSK maintains autoinhibition |
| B cell receptor (BCR) signaling | Phosphorylates ITAM motifs on Ig-α/Ig-β, initiating BCR signaling cascades |
| Associated Diseases | cancer |
| Interactions | ADRB2, AKT, AMPK, CD36, ERK1, FYN |
| KG Connections | 30 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
LYNPROTEIN["LYNPROTEIN"]
neurodegeneration["neurodegeneration"]
LYNPROTEIN -->|"implicated_in"| neurodegeneration
style LYNPROTEIN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning LYNPROTEIN in their description or question text
No additional research found